336 related articles for article (PubMed ID: 12820821)
1. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.
Krantz MJ; Kutinsky IB; Robertson AD; Mehler PS
Pharmacotherapy; 2003 Jun; 23(6):802-5. PubMed ID: 12820821
[TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
3. Torsade de pointes associated with very-high-dose methadone.
Krantz MJ; Lewkowiez L; Hays H; Woodroffe MA; Robertson AD; Mehler PS
Ann Intern Med; 2002 Sep; 137(6):501-4. PubMed ID: 12230351
[TBL] [Abstract][Full Text] [Related]
4. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
5. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
Krantz MJ
J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
[TBL] [Abstract][Full Text] [Related]
7. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Kao DP; Haigney MC; Mehler PS; Krantz MJ
Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
[TBL] [Abstract][Full Text] [Related]
9. Corrected QT Interval Prolongation in Hospitalized Pediatric Patients Receiving Methadone.
Schwinghammer AJ; Wilson MD; Hall BA
Pediatr Crit Care Med; 2018 Aug; 19(8):e403-e408. PubMed ID: 29894447
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
[TBL] [Abstract][Full Text] [Related]
11. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
12. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
Krantz MJ; Garcia JA; Mehler PS
Pharmacotherapy; 2005 Apr; 25(4):611-4. PubMed ID: 15977920
[TBL] [Abstract][Full Text] [Related]
13. Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.
Juba KM; Khadem TM; Hutchinson DJ; Brown JE
J Palliat Med; 2017 Jul; 20(7):722-728. PubMed ID: 28186837
[TBL] [Abstract][Full Text] [Related]
14. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.
Gil M; Sala M; Anguera I; Chapinal O; Cervantes M; Guma JR; Segura F
Am J Cardiol; 2003 Oct; 92(8):995-7. PubMed ID: 14556883
[TBL] [Abstract][Full Text] [Related]
15. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
[TBL] [Abstract][Full Text] [Related]
16. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Walroth TA; Ott CA; Desta Z; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Mar; 41(3):238-246. PubMed ID: 33345336
[TBL] [Abstract][Full Text] [Related]
17. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.
Ehret GB; Desmeules JA; Broers B
Expert Opin Drug Saf; 2007 May; 6(3):289-303. PubMed ID: 17480178
[TBL] [Abstract][Full Text] [Related]
18. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
[TBL] [Abstract][Full Text] [Related]
19. Methadone-induced Torsade de pointes tachycardias.
Sticherling C; Schaer BA; Ammann P; Maeder M; Osswald S
Swiss Med Wkly; 2005 May; 135(19-20):282-5. PubMed ID: 15986265
[TBL] [Abstract][Full Text] [Related]
20. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
